Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models
Compose a Response to This Article
Other responses
No responses have been published for this article.